Refers to article:
Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
Accepted 21 October 2012
March 2013 (Vol. 63, Issue 3, pages 462 - 472)
© 2012 European Association of Urology, Published by Elsevier B.V.